Health Care & Life Sciences » Pharmaceuticals | Strongbridge Biopharma PLC

Strongbridge Biopharma PLC

Strongbridge Biopharma PLC
Stock Exchange NASDAQ Stock Market
EPS
$0.32
Market Cap
$172.27 M
Shares Outstanding
54.16 M
Public Float
35.79 M

Profile

Address
900 Northbrook Drive
Lower Southampton Pennsylvania 19053
United States
Employees -
Website http://www.strongbridgebio.com
Updated 07/08/2019
Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.

Financials

View All

Matthew Pauls
President, Chief Executive Officer & Director
John H. Johnson
Chairman